Johnson & Johnson Asia Pacific Africa — Sales to customers (Note 9) increased by 0.2% to $3.61B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.0%, from $3.48B to $3.61B. Over 2 years (FY 2021 to FY 2024), Asia Pacific Africa — Sales to customers (Note 9) shows a downward trend with a -5.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market expansion or higher demand for products in these regions, while a decrease may signal competitive pressure or regional economic headwinds.
This metric represents the total revenue generated from external customers located within the Asia-Pacific and Africa ge...
Comparable to regional revenue reporting by other multinational pharmaceutical or consumer health companies, often categorized by geographic segment.
jnj_segment_asia_pacific_africa_sales_to_customers_note_9| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.37B | $4.36B | $4.29B | $4.32B | $4.51B | $4.20B | $4.25B | $4.31B | $3.46B | $3.41B | $3.45B | $3.48B | $3.26B | $3.31B | $3.61B | $3.61B |
| QoQ Change | — | -0.3% | -1.6% | +0.6% | +4.4% | -6.7% | +1.2% | +1.4% | -19.8% | -1.5% | +1.4% | +0.7% | -6.2% | +1.6% | +8.9% | +0.2% |
| YoY Change | — | — | — | — | +3.1% | -3.6% | -0.8% | -4.3% | -17.7% | — | -19.9% | +0.5% | — | -2.8% | +4.5% | +4.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.